Experimental studies have shown levels of angiogenin are reduced in a transgenic α-synuclein PD mouse model and exogenous angiogenin protects neuronal loss in 1-methyl-4-phenylpyridine (MPP+) treated cellular models of PD [8], [9]. Here, ANG is linked to Parkinson disease.